Camille Roux

ORCID: 0000-0001-7288-4325
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Drug-Induced Adverse Reactions
  • Prenatal Screening and Diagnostics
  • Contact Dermatitis and Allergies
  • Urticaria and Related Conditions
  • Ophthalmology and Visual Impairment Studies
  • Folate and B Vitamins Research
  • Retinal Development and Disorders
  • Nail Diseases and Treatments
  • Chemotherapy-related skin toxicity
  • Lichen and fungal ecology
  • Assisted Reproductive Technology and Twin Pregnancy
  • Nigella sativa pharmacological applications
  • Vascular Anomalies and Treatments
  • Pharmacological Effects of Natural Compounds
  • Dermatology and Skin Diseases
  • Parathyroid Disorders and Treatments
  • Autoimmune and Inflammatory Disorders
  • Autoimmune Bullous Skin Diseases
  • Retinal Diseases and Treatments
  • Vasculitis and related conditions
  • Reproductive Biology and Fertility
  • Systemic Sclerosis and Related Diseases
  • Food Allergy and Anaphylaxis Research
  • Magnesium in Health and Disease

Assistance Publique – Hôpitaux de Paris
2021-2023

Hôpital Cochin
2023

Université Paris Cité
2023

Hôpitaux Universitaires Henri-Mondor
2022

Centre Hospitalier Universitaire Henri-Mondor
2021

Centre hospitalier national d'ophtalmologie des Quinze-Vingts
2015

Inserm
2015

Franche-Comté Électronique Mécanique Thermique et Optique - Sciences et Technologies
2008

Centre National de la Recherche Scientifique
2008

Hôpital Dupuytren
2005-2008

<b><i>Introduction:</i></b> Retinitis pigmentosa (RP) is an inherited retinal disorder, characterized by photoreceptor degeneration inducing progressive vision loss. This study evaluates its impact on quality of life (QOL) and emotional states patients affected RP. <b><i>Methods:</i></b> A cross-sectional was conducted 60 RP diagnosed with rod-cone dystrophy 20 control subjects. The population has been divided into 3 groups according to visual...

10.1159/000435886 article EN cc-by-nc Ophthalmic Research 2015-01-01

Erythema multiforme (EM) may become long term, with a recurrent or persistent course. First-line treatment for chronic EM is valaciclovir. There no consensus selection of second-line EM.The aim this study was to assess the effectiveness thalidomide patients EM.In retrospective national multicenter cohort study, among 68 French hospital dermatology departments contacted by e-mail, 10 reported having eligible cases. All adults aged 18 years older under care (including and forms) who had...

10.1001/jamadermatol.2021.4083 article EN JAMA Dermatology 2021-11-11

The authors declares there is no potential conflict of interest.

10.1111/cod.14266 article EN Contact Dermatitis 2022-12-10
Coming Soon ...